Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ACXP
$1.40
-5.74%
ACXP · Acurx Pharmaceuticals, Inc.
$1.40
-0.09 (-5.74%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.35M
Shares
5.27M
All earnings calls
Earnings call · FY2021 Q2
Acurx Pharmaceuticals, Inc. Q2 FY2021 Earnings Call
Acurx Pharmaceuticals, Inc. Q2 FY2021 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Diluted EPS
-$11.40
Net income
-$4.00M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 16, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2021 · complete as-filed document